Trulieve Cannabis Corp.
TRLV
NYSE
Healthcare
$9.78
+2.52%gain today
Market position
Market cap rank
#2230
of 2,614
1-day
+2.52%
1-month
+4.94%
6-month
+12.54%
YTD
+12.41%
1-year
+154.69%
5-year
-73.74%
Key figures
Market cap
$1.66B
P/E (live)
—
price ÷ annual EPS
P/E (reported)
-14.2
FY 2025
EPS
-$0.61
FY 2025
Dividend yield
0.00%
FY 2025
Dividend / share
$0.00
Gross margin
60.21%
FY 2025
Operating margin
12.56%
FY 2025
Net margin
-9.85%
FY 2025
Return on equity
—
FY 2025
Valuation & financial health
Enterprise value
$1.97B
FY 2025
EV / EBITDA
6.00
FY 2025
EV / Sales
1.67
FY 2025
Price / book
1.43
FY 2025
Price / sales
1.41
FY 2025
Earnings yield
-7.00%
FY 2025
FCF yield
12.77%
FY 2025
Debt / equity
0.49
FY 2025
Current ratio
4.43
FY 2025
Return on assets
—
FY 2025
Return on invested capital
Financials · FY 2025
Revenue
$1.18B
Gross profit
$711.17M
Operating income
$148.32M
EBITDA
$328.33M
Net income
$-116.38M
Diluted EPS
-$0.61
Shares outstanding
191,300,000
Trading
Open
$9.64
Previous close
$9.54
Day range
$9.34 – $10.10
52-week range
$3.81 – $13.28
50-day avg
$9.25
200-day avg
$7.62
Volume
1,031,550
Avg volume
969,618
Beta
1.86
Price history
+154.69% over 1Y
Compare with peers
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Visit websiteCompany info
CEO
Kimberly A. Rivers
IPO date
Sep 25, 2018
Headquarters
Tallahassee, FL, US
Country
US
Fundamentals are annual. Figures labeled with their fiscal year.
